Faculty, Staff and Student Publications

Language

English

Publication Date

6-1-2024

Journal

Cancers

DOI

10.3390/cancers16112118

PMID

38893237

PMCID

PMC11171351

PubMedCentral® Posted Date

6-1-2024

PubMedCentral® Full Text Version

Post-print

Abstract

In this review, we aim to provide a summary of the diverse immunophenotypic presentations of distinct entities associated with plasmacytoid dendritic cell (pDC) proliferation. These entities include the following: (1) blastic plasmacytoid dendritic cell neoplasm (BPDCN); (2) mature pDC proliferation (MPDCP), most commonly seen in chronic myelomonocytic leukemia (CMML); and (3) myeloid neoplasms with pDC differentiation, in which pDCs show a spectrum of maturation from early immature pDCs to mature forms, most commonly seen in acute myeloid leukemia (pDC-AML). Our aim is to provide a flow cytometry diagnostic approach to these distinct and sometimes challenging entities and to clarify the immunophenotypic spectrum of neoplastic pDCs in different disease presentations. In this review, we also cover the strategies in the evaluation of residual disease, as well as the challenges and pitfalls we face in the setting of immune and targeted therapy. The differential diagnosis will also be discussed, as blasts in some AML cases can have a pDC-like immunophenotype, mimicking pDCs.

Keywords

flow cytometry analysis, plasmacytoid dendritic cells, blastic plasmacytoid dendritic cell neoplasm, BPDCN, mature plasmacytoid dendritic cell proliferation, MPDCP, AML with plasmacytoid dendritic cell differentiation, pDC-AML

Published Open-Access

yes

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.